1
|
Crowson CS, Matteson EL, Myasoedova E,
Michet CJ, Ernste FC, Warrington KJ, Davis JM III, Hunder GG,
Therneau TM and Gabriel SE: The lifetime risk of adult-onset
rheumatoid arthritis and other inflammatory autoimmune rheumatic
diseases. Arthritis Rheum. 63:633–639. 2011.PubMed/NCBI View Article : Google Scholar
|
2
|
Gonzalez-Gay MA, Vazquez-Rodriguez TR,
Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J and
Llorca J: Epidemiology of giant cell arteritis and polymyalgia
rheumatica. Arthritis Rheum. 61:1454–1461. 2009.PubMed/NCBI View Article : Google Scholar
|
3
|
Aiello PD, Trautmann JC, McPhee TJ,
Kunselman AR and Hunder GG: Visual prognosis in giant cell
arteritis. Ophthalmology. 100:550–555. 1993.PubMed/NCBI View Article : Google Scholar
|
4
|
Font C, Cid MC, Coll-Vinent B, López-Soto
A and Grau JM: Clinical features in patients with permanent visual
loss due to biopsy-proven giant cell arteritis. Br J Rheumatol.
36:251–254. 1997.PubMed/NCBI View Article : Google Scholar
|
5
|
Kermani TA, Warrington KJ, Crowson CS,
Ytterberg SR, Hunder GG, Gabriel SE and Matteson EL: Large-vessel
involvement in giant cell arteritis: A population-based cohort
study of the incidence-trends and prognosis. Ann Rheum Dis.
72:1989–1994. 2013.PubMed/NCBI View Article : Google Scholar
|
6
|
Arboix A, Bechich S, Oliveres M,
García-Eroles L, Massons J and Targa C: Ischemic stroke of unusual
cause: Clinical features, etiology and outcome. Eur J Neurol.
8:133–139. 2001.PubMed/NCBI View Article : Google Scholar
|
7
|
Ungprasert P, Wijarnpreecha K, Koster MJ,
Thongprayoon C and Warrington KJ: Cerebrovascular accident in
patients with giant cell arteritis: A systematic review and
meta-analysis of cohort studies. Semin Arthritis Rheum. 46:361–366.
2016.PubMed/NCBI View Article : Google Scholar
|
8
|
Hunder GG, Bloch DA, Michel BA, Stevens
MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY and
Lie JT: , et al: The American College of Rheumatology 1990
criteria for the classification of giant cell arteritis. Arthritis
Rheum. 33:1122–1128. 1990.PubMed/NCBI View Article : Google Scholar
|
9
|
Schmidt WA: Ultrasound in the diagnosis
and management of giant cell arteritis. Rheumatology (Oxford). 57
(Suppl 2):ii22–ii31. 2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Bajkó Z, Bălaşa R, Szatmári S, Rusu S,
Moţăţăianu A and Maier S: The role of ultrasound in the diagnosis
of temporal arteritis. Neurol Neurochir Pol. 49:139–143.
2015.PubMed/NCBI View Article : Google Scholar
|
11
|
Salvarani C, Della Bella C, Cimino L,
Macchioni P, Formisano D, Bajocchi G, Pipitone N, Catanoso MG,
Restuccia G, Ghinoi A and Boiardi L: Risk factors for severe
cranial ischemic events in an Italian population-based cohort of
patients with giant cell arteritis. Rheumatology (Oxford).
48:250–253. 2009.PubMed/NCBI View Article : Google Scholar
|
12
|
Gonzalez-Gay MA, Vazquez-Rodriguez TR,
Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Triñanes MC,
Miranda-Filloy JA, Blanco R, Dierssen T, Gonzalez-Juanatey C and
Llorca J: Strokes at time of disease diagnosis in a series of 287
patients with biopsy-proven giant cell arteritis. Medicine
(Baltimore). 88:227–235. 2009.PubMed/NCBI View Article : Google Scholar
|
13
|
Samson M, Jacquin A, Audia S, Daubail B,
Devilliers H, Petrella T, Martin L, Durier J, Besancenot JF,
Lorcerie B, et al: Stroke associated with giant cell arteritis: A
population-based study. J Neurol Neurosurg Psychiatry. 86:216–221.
2015.PubMed/NCBI View Article : Google Scholar
|
14
|
de Boysson H, Liozon E, Larivière D,
Samson M, Parienti JJ, Boutemy J, Maigné G, Martin Silva N, Ly K,
Touzé E, et al: Giant cell arteritis-related stroke: A
retrospective multicenter case-control study. J Rheumatol.
44:297–303. 2017.PubMed/NCBI View Article : Google Scholar
|
15
|
Zenone T and Puget M: Characteristics of
cerebrovascular accidents at time of diagnosis in a series of 98
patients with giant cell arteritis. Rheumatol Int. 33:3017–3023.
2013.PubMed/NCBI View Article : Google Scholar
|
16
|
Nesher G, Berkun Y, Mates M, Baras M,
Nesher R, Rubinow A and Sonnenblick M: Risk factors for cranial
ischemic complications in giant cell arteritis. Medicine
(Baltimore). 83:114–122. 2004.PubMed/NCBI View Article : Google Scholar
|
17
|
Koster MJ and Warrington KJ: Giant cell
arteritis: Pathogenic mechanisms and new potential therapeutic
targets. BMC Rheumatol. 1(2)2017.PubMed/NCBI View Article : Google Scholar
|
18
|
Piggott K, Biousse V, Newman NJ, Goronzy
JJ and Weyand CM: Vascular damage in giant cell arteritis.
Autoimmunity. 42:596–604. 2009.PubMed/NCBI View Article : Google Scholar
|
19
|
Harky A, Fok M, Balmforth D and Bashir M:
Pathogenesis of large vessel vasculitis: Implications for disease
classification and future therapies. Vasc Med. 24:79–88.
2019.PubMed/NCBI View Article : Google Scholar
|
20
|
Espígol-Frigolé G, Corbera-Bellalta M,
Planas-Rigol E, Lozano E, Segarra M, García-Martínez A,
Prieto-González S, Hernández-Rodríguez J, Grau JM, Rahman MU and
Cid MC: Increased IL-17A expression in temporal artery lesions is a
predictor of sustained response to glucocorticoid treatment in
patients with giant-cell arteritis. Ann Rheum Dis. 72:1481–1487.
2013.PubMed/NCBI View Article : Google Scholar
|
21
|
Terrier B, Geri G, Chaara W, Allenbach Y,
Rosenzwajg M, Costedoat-Chalumeau N, Fouret P, Musset L, Benveniste
O, Six A, et al: Interleukin-21 modulates Th1 and Th17 responses in
giant cell arteritis. Arthritis Rheum. 64:2001–2011.
2012.PubMed/NCBI View Article : Google Scholar
|
22
|
Cid MC, Hernández-Rodríguez J, Esteban MJ,
Cebrián M, Gho YS, Font C, Urbano-Márquez A, Grau JM and Kleinman
HK: Tissue and serum angiogenic activity is associated with low
prevalence of ischemic complications in patients with giant-cell
arteritis. Circulation. 106:1664–1671. 2002.PubMed/NCBI View Article : Google Scholar
|
23
|
Takahashi I, Takamura H, Gotoh S, Sasaki H
and Ishikawa T: Giant cell arteritis with subarachnoid haemorrhage
due to the rupture of inflammatory aneurysm of the posterior
inferior cerebellar artery. Acta Neurochir (Wien). 138:893–894.
1996.PubMed/NCBI View Article : Google Scholar
|
24
|
Dawson ET, Brown DA and Rabinstein AA:
Headache, TIA and subarachnoid haemorrhage: Dissecting an unusual
cause for stroke-like symptoms. BMJ Case Rep.
2017(bcr2017219927)2017.PubMed/NCBI View Article : Google Scholar
|
25
|
Gál R, Bălaşa R, Bajkó Z, Maier S, Simu I
and Bălaşa A: Lethal subarachnoid and intracerebral haemorrhage
associated with temporal arteritis. A case report. J Crit Care Med
(Targu Mures). 3:153–157. 2017.PubMed/NCBI View Article : Google Scholar
|
26
|
Turney TM, Garraway WM and Whisnant JP:
The natural history of hemispheric and brainstem infarction in
Rochester, Minnesota. Stroke. 15:790–794. 1984.PubMed/NCBI View Article : Google Scholar
|
27
|
Pariente A, Guédon A, Alamowitch S,
Thietart S, Carrat F, Delorme S, Capron J, Cacciatore C, Soussan M,
Dellal A, et al: Ischemic stroke in giant-cell arteritis: French
retrospective study. J Autoimmun. 99:48–51. 2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Caselli RJ, Hunder GG and Whisnant JP:
Neurologic disease in biopsy-proven giant cell (temporal)
arteritis. Neurology. 38:352–359. 1988.PubMed/NCBI View Article : Google Scholar
|
29
|
Elhfnawy AM, Elsalamawy D, Abdelraouf M,
Schliesser M, Volkmann J and Fluri F: Red flags for a concomitant
giant cell arteritis in patients with vertebrobasilar stroke: A
cross-sectional study and systematic review. Acta Neurol Belg.
120:1389–1398. 2020.PubMed/NCBI View Article : Google Scholar
|
30
|
García-García J, Ayo-Martín Ó,
Argandoña-Palacios L and Segura T: Vertebral artery halo sign in
patients with stroke: A key clue for the prompt diagnosis of giant
cell arteritis. Stroke. 42:3287–3290. 2011.PubMed/NCBI View Article : Google Scholar
|
31
|
Rüegg S, Engelter S, Jeanneret C, Hetzel
A, Probst A, Steck AJ and Lyrer P: Bilateral vertebral artery
occlusion resulting from giant cell arteritis: Report of 3 cases
and review of the literature. Medicine (Baltimore). 82:1–12.
2003.PubMed/NCBI View Article : Google Scholar
|
32
|
Säve-Söderbergh J, Malmvall BE, Andersson
R and Bengtsson BA: Giant cell arteritis as a cause of death.
Report of nine cases. JAMA. 255:493–496. 1986.PubMed/NCBI View Article : Google Scholar
|
33
|
Bajko Z, Filep RC, Maier S, Motataianu A,
Andone S and Balasa R: Bilateral vertebral artery occlusion without
stroke secondary to giant cell arteritis. Acta Reumatol Port.
44:270–272. 2019.PubMed/NCBI
|
34
|
Solans-Laqué R, Bosch-Gil JA,
Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J and
Vilardell-Tarres M: Stroke and multi-infarct dementia as presenting
symptoms of giant cell arteritis: Report of 7 cases and review of
the literature. Medicine (Baltimore). 87:335–344. 2008.PubMed/NCBI View Article : Google Scholar
|
35
|
Wilkinson IM and Russell RW: Arteries of
the head and neck in giant cell arteritis. A pathological study to
show the pattern of arterial involvement. Arch Neurol. 27:378–391.
1972.PubMed/NCBI View Article : Google Scholar
|
36
|
Siemonsen S, Brekenfeld C, Holst B,
Kaufmann-Buehler AK, Fiehler J and Bley TA: 3T MRI reveals extra-
and intracranial involvement in giant cell arteritis. AJNR Am J
Neuroradiol. 36:91–97. 2015.PubMed/NCBI View Article : Google Scholar
|
37
|
Bogousslavsky J, Deruaz JP and Regli F:
Bilateral obstruction of internal carotid artery from giant-cell
arteritis and massive infarction limited to the vertebrobasilar
area. Eur Neurol. 24:57–61. 1985.PubMed/NCBI View Article : Google Scholar
|
38
|
Caselli RJ: Giant cell (temporal)
arteritis: A treatable cause of multi-infarct dementia. Neurology.
40:753–755. 1990.PubMed/NCBI View Article : Google Scholar
|
39
|
Parra J, Domingues J, Sargento-Freitas J
and Santana I: Extensive intracranial involvement with multiple
dissections in a case of giant cell arteritis. BMJ Case Rep.
2014(bcr2014204130)2014.PubMed/NCBI View Article : Google Scholar
|
40
|
Proft F, Czihal M, Rémi J, Fesl G,
Woischke C and Koops HS: Fatal spontaneous bilateral vertebral
artery dissection in giant cell arteritis (GCA). J Vasc.
3(2)2017.
|
41
|
Bajkó Z, Bălaşa R, Moţăţăianu A, Bărcuţean
L, Stoian A, Stirbu N and Maier S: Malignant middle cerebral artery
infarction secondary to traumatic bilateral internal carotid artery
dissection. A case report. J Crit Care Med (Targu Mures).
2:135–141. 2016.PubMed/NCBI View Article : Google Scholar
|
42
|
Filep RC, Bajko Z, Simu IP and Stoian A:
Pseudo-dissection of the internal carotid artery in acute ischemic
stroke. Acta Neurol Belg. 120:469–472. 2020.PubMed/NCBI View Article : Google Scholar
|
43
|
Bajkó Z, Maier S, Moţăţăianu A, Bălaşa R,
Vasiu S, Stoian A and Andone S: Stroke secondary to traumatic
carotid artery injury-A case report. J Crit Care Med (Targu Mures).
4:23–28. 2018.PubMed/NCBI View Article : Google Scholar
|
44
|
Schmidt WA, Kraft HE, Völker L, Vorpahl K
and Gromnica-Ihle EJ: Colour Doppler sonography to diagnose
temporal arteritis. Lancet. 345(866)1995.PubMed/NCBI View Article : Google Scholar
|
45
|
Schmidt WA, Natusch A, Möller DE, Vorpahl
K and Gromnica-Ihle E: Involvement of peripheral arteries in giant
cell arteritis: A color Doppler sonography study. Clin Exp
Rheumatol. 20:309–318. 2002.PubMed/NCBI
|
46
|
Aschwanden M, Daikeler T, Kesten F, Baldi
T, Benz D, Tyndall A, Imfeld S, Staub D, Hess C and Jaeger KA:
Temporal artery compression sign-a novel ultrasound finding for the
diagnosis of giant cell arteritis. Ultraschall Med. 34:47–50.
2013.PubMed/NCBI View Article : Google Scholar
|
47
|
Schmidt WA: Role of ultrasound in the
understanding and management of vasculitis. Ther Adv Musculoskelet
Dis. 6:39–47. 2014.PubMed/NCBI View Article : Google Scholar
|
48
|
Baig IF, Pascoe AR, Kini A and Lee AG:
Giant cell arteritis: Early diagnosis is key. Eye Brain. 11:1–12.
2019.PubMed/NCBI View Article : Google Scholar
|
49
|
Bley TA, Wieben O, Uhl M, Thiel J, Schmidt
D and Langer M: High-resolution MRI in giant cell arteritis:
Imaging of the wall of the superficial temporal artery. AJR Am J
Roentgenol. 184:283–287. 2005.PubMed/NCBI View Article : Google Scholar
|
50
|
Pelletier-Galarneau M and Ruddy TD: PET/CT
for diagnosis and management of large-vessel vasculitis. Curr
Cardiol Rep. 21(34)2019.PubMed/NCBI View Article : Google Scholar
|
51
|
Nesher G, Berkun Y, Mates M, Baras M,
Rubinow A and Sonnenblick M: Low-dose aspirin and prevention of
cranial ischemic complications in giant cell arteritis. Arthritis
Rheum. 50:1332–1337. 2004.PubMed/NCBI View Article : Google Scholar
|
52
|
Lee MS, Smith SD, Galor A and Hoffman GS:
Antiplatelet and anticoagulant therapy in patients with giant cell
arteritis. Arthritis Rheum. 54:3306–3309. 2006.PubMed/NCBI View Article : Google Scholar
|
53
|
Narváez J, Bernad B, Gómez-Vaquero C,
García-Gómez C, Roig-Vilaseca D, Juanola X, Rodriguez-Moreno J,
Nolla JM and Valverde J: Impact of antiplatelet therapy in the
development of severe ischemic complications and in the outcome of
patients with giant cell arteritis. Clin Exp Rheumatol. 26:S57–S62.
2008.PubMed/NCBI
|
54
|
Martínez-Taboada VM, López-Hoyos M,
Narvaez J and Muñoz-Cacho P: Effect of antiplatelet/anticoagulant
therapy on severe ischemic complications in patients with giant
cell arteritis: A cumulative meta-analysis. Autoimmun Rev.
13:788–794. 2014.PubMed/NCBI View Article : Google Scholar
|
55
|
Bienvenu B, Ly KH, Lambert M, Agard C,
André M, Benhamou Y, Bonnotte B, de Boysson H, Espitia O, Fau G, et
al: Management of giant cell arteritis: Recommendations of the
French study group for large vessel vasculitis (GEFA). Rev Med
Interne. 37:154–165. 2016.PubMed/NCBI View Article : Google Scholar
|
56
|
Larivière D, Sacre K, Klein I, Hyafil F,
Choudat L, Chauveheid MP and Papo T: Extra- and intracranial
cerebral vasculitis in giant cell arteritis: An observational
study. Medicine (Baltimore). 93(e265)2014.PubMed/NCBI View Article : Google Scholar
|